John Cairns

Active 1960–2022

79
Papers
20,408
Citations
65
h-index
79
i10-index

Citations

Citations per year for John Cairns1967: 10 citations1968: 34 citations1969: 21 citations1970: 36 citations1971: 44 citations1972: 36 citations1973: 25 citations1974: 22 citations1975: 21 citations1976: 29 citations1977: 21 citations1978: 22 citations1979: 25 citations1980: 33 citations1981: 33 citations1982: 43 citations1983: 37 citations1984: 44 citations1985: 26 citations1986: 27 citations1987: 26 citations1988: 30 citations1989: 33 citations1990: 45 citations1991: 58 citations1992: 61 citations1993: 46 citations1994: 68 citations1995: 63 citations1996: 43 citations1997: 55 citations1998: 48 citations1999: 52 citations2000: 67 citations2001: 66 citations2002: 60 citations2003: 90 citations2004: 61 citations2005: 76 citations2006: 82 citations2007: 95 citations2008: 87 citations2009: 89 citations2010: 50 citations2011: 70 citations2012: 104 citations2013: 97 citations2014: 99 citations2015: 106 citations2016: 85 citations2017: 73 citations2018: 85 citations2019: 230 citations2020: 230 citations2021: 199 citations2022: 189 citations2023: 145 citations2024: 305 citations2025: 139 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,813 citing papers, 29.2% of this breakdownUnited Kingdom: 832 citing papers, 13.4% of this breakdownChina: 278 citing papers, 4.5% of this breakdownAustralia: 252 citing papers, 4.1% of this breakdownCanada: 251 citing papers, 4% of this breakdownGermany: 210 citing papers, 3.4% of this breakdownNetherlands: 176 citing papers, 2.8% of this breakdownFrance: 164 citing papers, 2.6% of this breakdownIndia: 144 citing papers, 2.3% of this breakdownSwitzerland: 143 citing papers, 2.3% of this breakdownItaly: 137 citing papers, 2.2% of this breakdownJapan: 127 citing papers, 2% of this breakdown
0%29.2%Other 27.2%

Fields

  • Medicine42.5%
  • Biochemistry, Genetics and Molecular Biology32.2%
  • Environmental Science5.4%
  • Health Professions4.1%
  • Economics, Econometrics and Finance3.9%
  • Agricultural and Biological Sciences1.7%
  • Other10.2%

Topics

  • DNA Repair Mechanisms4.3%
  • Bacterial Genetics and Biotechnology2.5%
  • DNA and Nucleic Acid Chemistry2.3%
  • HER2/EGFR in Cancer Research1.8%
  • Ophthalmology and Visual Impairment Studies1.7%
  • Mobile Health and mHealth Applications1.7%
  • Other85.7%

Coauthors

All papers

Open in search
  1. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suzanne Gilbert, Reeta Gurung, Esmael Habtamu, Peter W. H. Holland, Jost B. Jonas, Pearse A. Keane, Lisa Keay, Rohit Khanna, Peng T. Khaw, Hannah Kuper, Fatima Kyari, Van Charles Lansingh, Islay Mactaggart, Milka Mafwiri, Wanjiku Mathenge, Ian McCormick, Priya Morjaria, Lizette Mowatt, Debbie Muirhead, G. V. S. Murthy, Nyawira Mwangi, Daksha Patel, Tünde Pető, Babar Qureshi, Solange Rios Salomão, Virginia Sarah, Bernadetha Shilio, Anthony W. Solomon, Bonnielin K. Swenor, Hugh R. Taylor, Ningli Wang, Aubrey Webson, Sheila K. West, Tien Yin Wong, Richard Wormald, Sumrana Yasmin, Mayinuer Yusufu, Juan Carlos Silva, Serge Resnikoff, Thulasiraj Ravilla, Clare Gilbert, Allen Foster, Hannah Faal - The Lancet Global Health 2021 cited by 1,523

  2. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients

    Authors: , , , , , , , , , , , , - Health Technology Assessment 2013 cited by 775

  3. Global economic productivity losses from vision impairment and blindness

    Authors: , , , , , , , , , , , , - EClinicalMedicine 2021 cited by 224

  4. The economics of vision impairment and its leading causes: A systematic review

    Authors: , , , , , , , , , , , , , , , , , - EClinicalMedicine 2022 cited by 127

  5. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation

    Authors: , , , , , , , , , , , , , , , - Health Technology Assessment 2007 cited by 548

  6. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

    Authors: , , , , , , , , , , - Value in Health 2016 cited by 346

  7. Barriers to living donor kidney transplantation in the United Kingdom: a national observational study

    Authors: , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2017 cited by 98

  8. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial

    Authors: , , , , , , , , , - The Lancet 2011 cited by 764

  9. The origin of mutants

    Authors: , , - Nature 1988 cited by 1,037

  10. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy

    Authors: , , , , , , , , , , - Applied Health Economics and Health Policy 2022 cited by 34

  11. The bacterial chromosome and its manner of replication as seen by autoradiography

    Authors: - Journal of Molecular Biology 1963 cited by 764

  12. Recipient Comorbidity and Survival Outcomes After Kidney Transplantation: A UK-wide Prospective Cohort Study

    Authors: , , , , , , , , , , , , , , - Transplantation 2019 cited by 55

  13. “Don’t Think Twice, It’s All Right”: Using Additional Data to Reduce Uncertainty Regarding Oncologic Drugs Provided Through Managed Access Agreements in England

    Authors: , - PharmacoEconomics - Open 2022 cited by 26

  14. Adaptive reversion of a frameshift mutation in Escherichia coli.

    Authors: , - Genetics 1991 cited by 495

  15. Mechanical Properties of Corrosion-Damaged Reinforcement

    Authors: , , , , - ACI Materials Journal 2005 cited by 418

  16. Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial

    Authors: , , , , , - PLoS ONE 2011 cited by 195

  17. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop

    Authors: , , , , , - The European Journal of Health Economics 2012 cited by 174

  18. Evaluation of modernisation of adult critical care services in England: time series and cost effectiveness analysis

    Authors: , , , , , , , - BMJ 2009 cited by 115

  19. A new pathway for DNA repair in Escherichia coli

    Authors: , - Nature 1977 cited by 706

  20. The segregation of DNA in epithelial stem cells

    Authors: , , , - Cell 1978 cited by 307

  21. Prospective epidemiologic study of the outcome and cost‐effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti‐HPA‐1a

    Authors: , , , , , , , , , , - Transfusion 2005 cited by 147

  22. Estimating Population-Based Values for EQ-5D Health States in Thailand

    Authors: , - Value in Health 2011 cited by 139

  23. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation – the CASCADE study

    Authors: , , , , , , , , , , , , , , , , , , , , - Health Technology Assessment 2014 cited by 94

  24. Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway

    Authors: , , , , , , - Quality of Life Research 2021 cited by 20